PRFX — PRF Technologies Share News
0.000.00%
Last trade - 00:00- $2.25m
- -$5.67m
- $0.02m
Brief: PainReform reports Q2 results
Brief: PainReform announces receipt of NASDAQ minimum bid price notification
Incurred A Net Loss Of $1.7 Mln For The Three Months Ended March 31, 2022
Brief: Painreform Provides Year-End Business Update On Track To Commence Phase 3 Trial Of Prf-110 For Non-Opiate Post-Operative Pain Relief In Second Half Of 2022
Brief: PainReform Provides Business Update for the Third Quarter of 2021
Brief: PainReform Ltd Files For Mixed Shelf Of Up To $100 Million
U.S. STOCKS ON THE MOVE-Alibaba, Gap, Apple, Workday
PainReform Ltd reports results for the quarter ended in June - Earnings Summary
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:13 PM
NASDAQ RESUMED AT 11:19 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:14 AM
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
U.S. STOCKS ON THE MOVE-Crocs, NeuroMetrix, Seres Therapeutics
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
PainReform Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Painreform Provides Year-End Business Update And Reports Progress Towards Commencing Phase 3 Trial Of Prf-110 For Non-Opiate Post-Operative Pain Relief